Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice

Journal of Clinical Investigation

Volumn 119, Issue 7, 2009, Pages 1899-1909

  Zhang, Zhe ^a   Clarke, Thomas B ^a   Weiser, Jeffrey N ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLODRONIC ACID; INTERLEUKIN 17; LIPOSOME; TLR2 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 2;

ANIMAL; C57BL MOUSE; CD4+ T LYMPHOCYTE; IMMUNOLOGY; MACROPHAGE; MONOCYTE; MOUSE; PHYSIOLOGY; PNEUMOCOCCAL INFECTION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CLODRONIC ACID; INTERLEUKIN-17; LIPOSOMES; MACROPHAGES; MICE; MICE, INBRED C57BL; MONOCYTES; PNEUMOCOCCAL INFECTIONS; TOLL-LIKE RECEPTOR 2;

EID: 68449085481     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/jci36731     Document Type: Article

References (55)

1. Cutts, F.T., et al. 2005. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet. 365:1139-1146.
2. Kadioglu, A., Weiser, J.N., Paton, J.C., and Andrew, P.W. 2008. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat. Rev. Microbiol. 6:288-301.
3. Austrian, R. 1986. Some aspects of the pneumococcal carrier state. J. Antimicrob. Chemother. 18:35-45.
4. Bogaert, D., De Groot, R., and Hermans, P.W. 2004. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet. Infect. Dis. 4:144-154.
5. Syrjanen, R.K., Kilpi, T.M., Kaijalainen, T.H., Herva, E.E., and Takala, A.K. 2001. Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old. J. Infect. Dis. 184:451-459.
6. McCool, T.L., Cate, T.R., Moy, G., and Weiser, J.N. 2002. The immune response to pneumococcal proteins during experimental human carriage. J. Exp. Med. 195:359-365.
7. Goldblatt, D., et al. 2005. Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study. J. Infect. Dis. 192:387-393.
8. MacLeod, C.M., Hodges, R.M., Heidelberger, M., and Bernhard, W.G. 1945. Prevention of pneumococcal infection by immunization with capsular polysaccharides of Streptococcus pneumoniae. J. Exp. Med. 82:445-465.
9. Dagan, R., et al. 2005. Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus. J. Infect. Dis. 192:367-376.
10. Mbelle, N., et al. 1999. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J. Infect. Dis. 180:1171-1176.
11. McCool, T.L., and Weiser, J.N. 2004. Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization. Infect. Immun. 72:5807-5813.
12. Lipsitch, M., et al. 2005. Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease? PLoS Med. 2:e15.
13. Malley, R., et al. 2004. Multiserotype protection of mice against pneumococcal colonization of the nasopharynx and middle ear by killed nonencapsulated cells given intranasally with a nontoxic adjuvant. Infect. Immun. 72:4290-4292.
14. Malley, R., et al. 2005. CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc. Natl. Acad. Sci. U. S. A. 102:4848-4853.
15. Malley, R., et al. 2006. Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Infect. Immun. 74:2187-2195.
16. Trzcinski, K., et al. 2008. Protection against nasopharyngeal colonization by Streptococcus pneumoniae is mediated by antigen-specific CD4+ T cells. Infect. Immun. 76:2678-2684.
17. Madhi, S.A., et al. 2007. Long-term effect of pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae - and associated interactions with Staphylococcus aureus and Haemophilus influenzae colonization - in HIV-Infected and HIV-uninfected children. J. Infect. Dis. 196:1662-1666.
18. van Rossum, A.M., Lysenko, E.S., and Weiser, J.N. 2005. Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model. Infect. Immun. 73:7718-7726.
19. Akira, S. 2006. TLR signaling. Curr. Top. Microbiol. Immunol. 311:1-16.
20. Kabelitz, D. 2007. Expression and function of Toll-like receptors in T lymphocytes. Curr. Opin. Immunol. 19:39-45.
21. Malley, R., et al. 2003. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad. Sci. U. S. A. 100:1966-1971.
22. Kadioglu, A., Coward, W., Colston, M.J., Hewitt, C.R., and Andrew, P.W. 2004. CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection. Infect. Immun. 72:2689-2697.
23. Lu, Y.J., et al. 2008. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 4:e1000159.
24. Matthias, K.A., Roche, A.M., Standish, A.J., Shchepetov, M., and Weiser, J.N. 2008. Neutrophiltoxin interactions promote antigen delivery and mucosal clearance of Streptococcus pneumoniae. J. Immunol. 180:6246-6254.
25. Bergeron, Y., et al. 1998. Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice. Infect. Immun. 66:912-922.
26. Sun, K., and Metzger, D.W. 2008. Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat. Med. 14:558-564.
27. Heffron, R. 1979. Pneumonia, with special reference to pneumococcus lobar pneumonia. Harvard University Press. Cambridge, Massachusetts, USA. 1086 pp.
28. Taut, K., et al. 2008. Macrophage turnover kinetics in the lungs of mice infected with Streptococcus pneumoniae. Am. J. Respir. Cell Mol. Biol. 38:105-113.
29. Maus, U., et al. 2001. Monocytes recruited into the alveolar air space of mice show a monocytic phenotype but upregulate CD14. Am. J. Physiol. Lung Cell Mol. Physiol. 280:L58-L68.
30. Raquil, M.A., Anceriz, N., Rouleau, P., and Tessier, P.A. 2008. Blockade of antimicrobial proteins S100A8 and S100A9 inhibits phagocyte migration to the alveoli in streptococcal pneumonia. J. Immunol. 180:3366-3374.
31. Park, H., et al. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6:1133-1141.
32. Harrington, L.E., et al. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6:1123-1132.
33. Bettelli, E., et al. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 441:235-238.
34. Beisswenger, C., Lysenko, E.S., and Weiser, J.N. 2009. Early bacterial colonization induces toll-like receptor-dependent transforming growth factor beta signaling in the epithelium. Infect. Immun. 77:2212-2220.
35. Miyamoto, M., et al. 2003. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J. Immunol. 170:4665-4672.
36. Kolls, J.K., and Linden, A. 2004. Interleukin-17 family members and inflammation. Immunity. 21:467-476.
37. Sergejeva, S., Ivanov, S., Lotvall, J., and Linden, A. 2005. Interleukin-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation. Am. J. Respir. Cell Mol. Biol. 33:248-253.
38. Basset, A., et al. 2007. Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins. Infect. Immun. 75:5460-5464.
39. Aujla, S.J., Dubin, P.J., and Kolls, J.K. 2007. Th17 cells and mucosal host defense. Semin. Immunol. 19:377-382.
40. van Lookeren Campagne, M., Wiesmann, C., and Brown, E.J. 2007. Macrophage complement receptors and pathogen clearance. Cell. Microbiol. 9:2095-2102.
41. Rehm, S.R., and Coonrod, J.D. 1982. Early clearance of pneumococci from the lungs of decomplemented rats. Infect. Immun. 36:24-29.
42. Gould, J.M., and Weiser, J.N. 2001. Expression of C-reactive protein in the human respiratory tract. Infect. Immun. 69:1747-1754.
43. Szalai, A.J., Briles, D.E., and Volanakis, J.E. 1995. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. J. Immunol. 155:2557-2563.
44. Gould, J.M., and Weiser, J.N. 2002. The inhibitory effect of C-reactive protein on bacterial phosphorylcholine platelet-activating factor receptor-mediated adherence is blocked by surfactant. J. Infect. Dis. 186:361-371.
45. Kuronuma, K., et al. 2004. Pulmonary surfactant protein A augments the phagocytosis of Streptococcus pneumoniae by alveolar macrophages through a casein kinase 2-dependent increase of cell surface localization of scavenger receptor A. J. Biol. Chem. 279:21421-21430.
46. Koppel, E.A., Litjens, M., van den Berg, V.C., van Kooyk, Y., and Geijtenbeek, T.B. 2008. Interaction of SIGNR1 expressed by marginal zone macrophages with marginal zone B cells is essential to early IgM responses against Streptococcus pneumoniae. Mol. Immunol. 45:2881-2887.
47. Arredouani, M., et al. 2004. The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles. J. Exp. Med. 200:267-272.
48. Takeuchi, O., et al. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 11:443-451.
49. Weiser, J.N., Austrian, R., Sreenivasan, P.K., and Masure, H.R. 1994. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect. Immun. 62:2582-2589.
50. Roche, A.M., King, S.J., and Weiser, J.N. 2007. Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice. Infect. Immun. 75:2469-2475.
51. Cotter, M.J., Norman, K.E., Hellewell, P.G., and Ridger, V.C. 2001. A novel method for isolation of neutrophils from murine blood using negative immunomagnetic separation. Am. J. Pathol. 159:473-481.
52. Van Rooijen, N. 1989. The liposome-mediated macrophage 'suicide' technique. J. Immunol. Methods. 124:1-6.
53. Pan, Z.K., Ikonomidis, G., Lazenby, A., Pardoll, D., and Paterson, Y. 1995. A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours. Nat. Med. 1:471-477.
54. Lysenko, E.S., Ratner, A.J., Nelson, A.L., and Weiser, J.N. 2005. The role of innate immune responses in the outcome of interspecies competition for colonization of mucosal surfaces. PLoS Pathog. 1:e1.
55. [No authors listed]. 2008. Guide to performing relative quantitation of gene expression using real-time quantitative PCR. Applied Biosystems Inc. Foster City, California, USA. http://www3.appliedbiosystems.com/cms/groups/mcb- support/documents/generaldocuments/cms-042380.pdf.